Colinz Labs

{
  "main_header": {
    "sid": 621096,
    "name": "Colinz Labs",
    "stock_name": "Colinz Labs",
    "full_name": "Colinz Laboratories Ltd",
    "name_url": "stocks-analysis/colinz-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "62.18",
    "chg": 2.96,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "59.22",
    "mcapval": "16.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531210,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE923C01011",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "23:56 PM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "3.83 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/colinz-labs-621096-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Colinz Laboratories Ltd Gains 15.30%: Technical Upgrades Amidst Flat Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-gains-1530-technical-upgrades-amidst-flat-fundamentals-4052386",
        "imagepath": "",
        "date": "2026-06-13 17:22:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Upgrade to Sell rating on technical improvements despite weak fundamentals</p>\n                    <p><strong>2 June:</strong> Further upgrade to Hold as technicals strengthen amid flat financials</p>\n                    <p><strong>3 June:</strong> Downgrade back to Sell amid mixed technical signals and fair valuation</p>\n                    <p><strong>4 June:</strong> Valuation shifts signal changing market sentiment</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.61.65, up 15.30% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div>..."
      },
      {
        "title": "Colinz Laboratories Declines 11.31% Amid Valuation Upgrade and Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-declines-1131-amid-valuation-upgrade-and-mixed-market-sentiment-4051384",
        "imagepath": "",
        "date": "2026-06-13 13:01:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.61.90, marginal gain amid Sensex decline</p>\n                    <p><strong>9 Jun:</strong> Rating upgraded to Hold on attractive valuation</p>\n                    <p><strong>10 Jun:</strong> Valuation metrics signal renewed price appeal</p>\n                    <p><strong>12 Jun:</strong> Stock recovers slightly to close at Rs.54.68</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.61.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.54.68</div><div..."
      },
      {
        "title": "Colinz Laboratories Ltd Upgraded to Hold on Attractive Valuation and Stable Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/colinz-laboratories-ltd-upgraded-to-hold-on-attractive-valuation-and-stable-fundamentals-4043342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_mojoScore_4043342.png",
        "date": "2026-06-10 08:04:44",
        "description": "Colinz Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and steady financial trends despite flat quarterly results. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4043168",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_valuationdot_4043168.png",
        "date": "2026-06-10 08:00:58",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, prompting an upgrade in its Mojo Grade from Sell to Hold. Despite a recent 4.98% dip in share price, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more attractive entry point relative to its historical and peer averages, signalling potential value for discerning investors."
      },
      {
        "title": "Colinz Laboratories Ltd Downgraded to Sell Amid Mixed Technicals and Fair Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/colinz-laboratories-ltd-downgraded-to-sell-amid-mixed-technicals-and-fair-valuation-4035379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_mojoScore_4035379.png",
        "date": "2026-06-04 08:05:40",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 3 June 2026. This shift reflects a complex interplay of technical improvements, valuation adjustments, and subdued financial trends, prompting a reassessment of the stock’s attractiveness despite recent price gains."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-signal-changing-market-sentiment-4035107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_valuationdot_4035107.png",
        "date": "2026-06-04 08:00:26",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation grade downgraded from attractive to fair, reflecting a notable shift in price attractiveness despite robust long-term returns. The company’s price-to-earnings (P/E) ratio now stands at 30.57, signalling a more cautious stance among investors amid evolving market dynamics and sector comparisons."
      },
      {
        "title": "Colinz Laboratories Ltd Upgraded to Hold as Technicals Improve Amid Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/colinz-laboratories-ltd-upgraded-to-hold-as-technicals-improve-amid-flat-financials-4032917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_mojoScore_4032917.png",
        "date": "2026-06-03 08:04:05",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 2 June 2026. This revision reflects a combination of improved technical indicators, attractive valuation metrics, and a cautiously optimistic financial trend despite flat recent results. The upgrade signals a more balanced outlook for investors amid mixed fundamental signals and a strengthening price momentum."
      },
      {
        "title": "Colinz Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/colinz-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4029917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_mojoScore_4029917.png",
        "date": "2026-06-02 08:10:58",
        "description": "Colinz Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The pharmaceutical company’s stock price rose 4.99% on 2 June 2026, reflecting renewed investor interest amid a mildly bullish technical trend, even as financial performance remains flat and valuation metrics suggest cautious optimism."
      },
      {
        "title": "Colinz Laboratories Declines 1.68%: Downgrade and Mixed Q4 Results Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-declines-168-downgrade-and-mixed-q4-results-shape-the-week-3971730",
        "imagepath": "",
        "date": "2026-05-02 16:05:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock opens at Rs.45.00 after downgrade announcement</p>\n                    <p><strong>28 Apr:</strong> Mojo Grade downgraded to Strong Sell amid weak fundamentals</p>\n                    <p><strong>29 Apr:</strong> Stock rallies 4.00% on increased volume</p>\n                    <p><strong>30 Apr:</strong> Q4 FY25 results reveal profit surge but revenue stagnation; stock dips 3.64%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.46.89</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..."
      }
    ],
    "total": 614,
    "sid": "621096",
    "stock_news_url": "https://www.marketsmojo.com/news/colinz-laboratories-621096"
  },
  "announcements": [
    {
      "caption": "Open Offer - Public Announcement",
      "datetime": "18-Jun-2026",
      "details": "Saffron Capital Advisors Private Limited (Manager to the Offer) has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 ead with Regulations 13 14 and 15(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended for the attention of the Public Shareholders of Colinz Laboratories Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Open Offer - Updates",
      "datetime": "18-Jun-2026",
      "details": "Please the attached disclosure under regularion 30 and 30A of SEBI (LODR) Regulation 2015. towards Sales of Promoter Shares. The details informatiom is attahced in the below attachement. Kindly take the same on records. For Colinz Labs Ltd Vijaya Mani",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Significant Movement In Share Price",
      "datetime": "11-Jun-2026",
      "details": "This has reference to your mail asking clarification on 01-06-2026. Please find our reply and also clarification for significant movment in our share price in this month. Kindly ccept and update the same at your end For Colinz Labs Ltd Ganesh Chitte CFO",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Colinz Laboratories Ltd Gains 15.30%: Technical Upgrades Amidst Flat Fundamentals

2026-06-13 17:22:20

Key Events This Week

1 June: Upgrade to Sell rating on technical improvements despite weak fundamentals

2 June: Further upgrade to Hold as technicals strengthen amid flat financials

3 June: Downgrade back to Sell amid mixed technical signals and fair valuation

4 June: Valuation shifts signal changing market sentiment

5 June: Week closes at Rs.61.65, up 15.30% for the week

Week Open

...

Read full news article

Colinz Laboratories Declines 11.31% Amid Valuation Upgrade and Mixed Market Sentiment

2026-06-13 13:01:19

Key Events This Week

8 Jun: Stock opens at Rs.61.90, marginal gain amid Sensex decline

9 Jun: Rating upgraded to Hold on attractive valuation

10 Jun: Valuation metrics signal renewed price appeal

12 Jun: Stock recovers slightly to close at Rs.54.68

Week Open

Rs.61.65

Week Close

Rs.54.68

Read full news article

Colinz Laboratories Ltd Upgraded to Hold on Attractive Valuation and Stable Fundamentals

2026-06-10 08:04:44

Colinz Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and steady financial trends despite flat quarterly results. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts.

Read full news article

Colinz Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-10 08:00:58

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, prompting an upgrade in its Mojo Grade from Sell to Hold. Despite a recent 4.98% dip in share price, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more attractive entry point relative to its historical and peer averages, signalling potential value for discerning investors.

Read full news article

Colinz Laboratories Ltd Downgraded to Sell Amid Mixed Technicals and Fair Valuation

2026-06-04 08:05:40

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 3 June 2026. This shift reflects a complex interplay of technical improvements, valuation adjustments, and subdued financial trends, prompting a reassessment of the stock’s attractiveness despite recent price gains.

Read full news article

Colinz Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment

2026-06-04 08:00:26

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation grade downgraded from attractive to fair, reflecting a notable shift in price attractiveness despite robust long-term returns. The company’s price-to-earnings (P/E) ratio now stands at 30.57, signalling a more cautious stance among investors amid evolving market dynamics and sector comparisons.

Read full news article

Colinz Laboratories Ltd Upgraded to Hold as Technicals Improve Amid Flat Financials

2026-06-03 08:04:05

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 2 June 2026. This revision reflects a combination of improved technical indicators, attractive valuation metrics, and a cautiously optimistic financial trend despite flat recent results. The upgrade signals a more balanced outlook for investors amid mixed fundamental signals and a strengthening price momentum.

Read full news article

Colinz Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-06-02 08:10:58

Colinz Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The pharmaceutical company’s stock price rose 4.99% on 2 June 2026, reflecting renewed investor interest amid a mildly bullish technical trend, even as financial performance remains flat and valuation metrics suggest cautious optimism.

Read full news article

Colinz Laboratories Declines 1.68%: Downgrade and Mixed Q4 Results Shape the Week

2026-05-02 16:05:35

Key Events This Week

27 Apr: Stock opens at Rs.45.00 after downgrade announcement

28 Apr: Mojo Grade downgraded to Strong Sell amid weak fundamentals

29 Apr: Stock rallies 4.00% on increased volume

30 Apr: Q4 FY25 results reveal profit surge but revenue stagnation; stock dips 3.64%

Week Open

Rs.46.89

Week Close

Read full news article

View All News